Posted: Tuesday, July 10, 2018
Emily S. Ruiz, MD, MPH, of Brigham and Women’s Cancer Center, discusses current recommendations on the treatment of squamous cell skin cancer and what she sees on the therapeutic horizon.
Cemiplimab-rwlc in Cutaneous Squamous Cell Carcinoma
NEW Cemiplimab Combination Treatment for Solid Organ Transplant Recipients
Cetuximab (Non-Melanoma Skin Cancers)
UPDATE Cemiplimab in Cutaneous Squamous Cell Carcinoma
AIM at Skin Cancer Offers Clinician Guidance on Patient Resources and Education
Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care Project
